Affective and anxiety disorders and drug addiction;Affektive und Angststörungen und Substanzabhängigkeit

Suchtmedizin in Forschung und Praxis

Volumn 15, Issue 6, 2013, Pages 341-348

  Soyka, Michael ^a,b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Privatklinik Meiringen Willigen ^*  (Switzerland)

Author keywords

Affective disorder; Alcohol dependence; Comorbidity; Drug dependence; Schizophrenia; Therapy

Indexed keywords

ANTIDEPRESSANT AGENT; MOOD STABILIZER;

ANXIETY DISORDER; ARTICLE; BEHAVIOR THERAPY; BIPOLAR DISORDER; CLINICAL FEATURE; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG INDICATION; HUMAN; LONG TERM CARE; MENTAL HEALTH CENTER; MOOD DISORDER; PHYSICIAN; PROGNOSIS; PSYCHOTHERAPY; TRANQUILIZING ACTIVITY; TREATMENT INDICATION;

EID: 84892146681     PISSN: 14375567     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. Agosti V, Levin FR (2006): The effects of alcohol and drug dependence on the course of depression. Am J Addict 15: 71-75
2. Aichmüller C, Soyka M (2013): Stationäre Therapie Suchtkranker mit komorbiden Störungen. Suchtmed 15: 21-32
3. Avants SK, Margolin A, Kosten TR, Rounsaville BJ, Schottenfeld RS (1998): When is less treatment better? The role of social anxiety in matching methadone patients to psychosocial treatments. J Consult Clin Psychology 66: 924-931
4. Baker AL, Kavanagh DJ, Kay-Lambkin FJ, Hunt SA, Lewin TJ, Carr VJ, Connolly J (2009): Randomized controlled trial of cognitive-behavioural therapy for coexisting depression and alcohol problems: short-term outcome. Addiction 105: 87-99
5. Ballie A, Sannibal C (2007): Anxiety and drug and alcohol problems. In: Baker A, Velleman R (eds.): Clinical handbook of co-existing mental health and drug and alcohol problems. Routledge, London 197-217
6. Bandelow BM Zohar J, Hollander E, Kasper S, Möller H-J (2008): World Federation of Societies of Biological Psychaitry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders - First Revision. World J Biological Psychiatry 9: 248-312
7. Bibb JL, Chambless DL (1986): Alcohol use and abuse among diagnosed agoraphobics. Behav Res Ther 24 (1): 49-58
8. Börner RJ, Möller HJ (1998): Differentielle Therapiestrategien bei Sozialer Phobie. Nervenheilkunde 17: 127-133
9. Boschloo L, Vogelzangs N, Smith JH, van den Brink W, Veltman DJ, Beekman AT, Penninx BW (2011): Comorbidity and risk factors for alcohol use disorders among persons with anxiety and/or depressive disorders: findings from the Netherlands Study of depression and Anxiety (NESDA). J Affect Disord 131: 233-242
10. Boschloo L, van den Brink W, Penninx BW, Wall MM, Hasin DS (2012): Alcohol-use disorder severity predicts first-incidence of depressive disorders. Psychol Med 42: 695-703
11. Boschloo L, Vogelzangs N, van den Brink W, Smit JH, Veltman DJ, Beekman AT, Penninx BW (2012): Alcohol use disorders and the course of depressive and anxiety disorders. Br J Psychiatry 200: 476-484
12. Buckner JD, Timpano KR, Zvolensky MJ et al. (2008): Implications of comorbid alcohol dependence among individuals with social anxiety disorder. Depress Anxiety 25: 1028-1037
13. Compton WM, Thomas YF, Stinson FS, Grant BF (2007): Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 64: 566-576
14. Cornelius JR, Salloum IM, Ehler JG et al. (1997): Fluoxetine in depressed alcoholics: a double-blind, placebo-controlled trial. Arch Gen Psychiatry 53: 232-240
15. De Soto CB,O'Donell WE, Allred LJ, Lopes CE (1985): Symptomatology in alcoholics at vari-ous stages of abstinence. Alcohol Clin Exp Res 9 (6): 505-512
16. Driessen M, Meier S, Hill A et al. (2001): The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without co-morbid anxiety and depressive disorders. Alcohol Alcohol 36: 249-255
17. Driessen M, Schulte S, Luedecke C et al. (2008): Trauma and PTSD in patients with alcohol, drug, or dual dependence: a multi-center study. Alcohol Clin Exp Res 32: 481-488
18. Farren CK, Scimeca M, Wu R, Mailey SO (2009): A double-blind, placebocontrolled study of sertraline with naltrexone for alcohol dependence. Drug Alcohol Depend 99: 317-321
19. Farris SG, Epstein EE, McCrady BS, Hunter-Reel D (2012): Do Co-morbid Anxiety disorders Predict Drinking Outcomes in Women with Alcohol use Disorders? Alcohol Alcohol 47: 143-148
20. Flensborg-Madsen T, Becker U, Gronbaek M, Knop J, Sher L, Mortensen EL (2011): Alcohol consumption and alter risk of hospitalization with psychiatric disorders: Prospective cohort study. Psychiatry Res 187: 214-219
21. George DT, Nutt DJ, Dwyer BA, Linnoila M (1990): Alcoholism and panic disorder: is the comorbidity more than coincidence? Acta Psychiatr Scand 81(2): 97-107
22. Gillihan SJ, Farris SG, Foa EB (2011): The effect of anxiety sensitivity on alcohol consumption among individuals with comorbid alcohol dependence and posttraumatic stress disorder. Psychol Addict Behav 25: 721-726
23. Grant BF, Hasin DS, Stinson FS, Dawson DA, June Ruan W, Goldstein RB, Smith SM, Saha TD, Huang B (2005): Prevalence, correlates, comorbidity, and comparative disability to DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med 35: 1747-1759
24. Haver B, Gjestad R (2005): Phobic anxiety and depression as predictor variables for treatment outcome. A LISREL analysis on treated female alcoholics. Nord J Psychiat 59: 25-30
25. Iovieno N, Tedeschini E, Benley KH, Evins AE, Papakostas GI (2011): Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials. J Clin Psychiatry 72: 1144-1151
26. Kelly TM, Daley DC et al. (2012): Treatment of substance abusing patients with comorbid psychiatric disorders. Addict Behav 37: 11-24
27. Kessler RC, Avenevoli S, Costello EJ, Georgiades K, Greif Green J, Gruber MJ, He HM, Koretz D, Mc. Laughlin KA, Petukhova M, Sampson NA, Zaslavsky AM, Ries Merikangas K (2012): Prevalence, Persistence, and Sociodemographic Correlates of DSM-IV Disorders in the National Comorbidity Survey Replication Adolescent Supplement. Arch Gen Psychiatry 69: 372-380
28. Kessler RC, Chiu WT, Demler O, Meikangas KR, Walters EE (2005): Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62: 617-627
29. Kessler RC, Crum RM, Warner LA et al. (1997): Lifetime co-occurence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the national comorbidity survey. Arch Gen Pychiatry 54: 313-321
30. Kranzler HR, Mueller T, Cornelius J, Pettinati HM, Moak D, Martin PR, Anthenelli R, Brower KJ, O'Malley S, Mason BJ, Hasin D, Keller M (2006): Sertraline treatment of co-occurring alcohol dependence and major depression. J Clin Psychopharmacol 26: 13-20
31. Kranzler HR, Mueller T, Cornelius J, Pettinati HM, Moak D, Martin PR, Anthenelli R, Brower KJ, O'Malley S, Mason BJ, Hasin D, Keller M (2006):Sertraline treatment of co-occuring alcohol dependence and major depression. J Clin Psychopharmacol 26: 13-20
32. Krystal JH, Staley J, Mason G, Petrakis IL, Kaufmann J, Harris RA, Gelernter J, Lappalainen J (2006): y-Aminobutyric acid type A receptors and alcoholism: intoxication, dependence, vulnerability, and treatment. Arch Gen Psychiatry 63(9): 957-968
33. Kushner MG, Abrams K, Borchardt C (2000): The relationship between anxiety disorders and alcohol use disorders: A review of major perspectives and findings. Clinical Psychology Review 20: 149-171
34. Kushner MG, Abrams K, Thuras P et al. (2005): Follow-up study of anxiety disorder and alcoholism treatment patients. Alcohol Clin Exp Res 29: 1432-1443
35. Kushner MG, Abrams K, Thuras P, Hanson KL (2000): Individual differences predictive of drinking to manage anxiety among non-problem drinkers with panic disorder. Alcohol Clin Exp Res 24: 448-458
36. Kushner MG, Donahue C Sletten S et al. (2006): Cognitive behavioural treatment of comorbied anxiety disorder in alcoholism treatment patients: presentation of aprototype program and future directions. J Ment Health 15: 698-707
37. Kushner MG, Mackenzie TB, Fiszdon J, Valentiner DP, Foa E, Wangensteen D (1996): The effects of alcohol consumption on laboratory induced panic and state anxiety. Arch Gen Psychiatry 53: 264-270
38. Leray E, Camara A, Draper D, Riou F, bougeant N, Pelissolo A, Lloyd KR, Bellamy V, Roelandt JL, Millet B (2011): Prevalence, characteristics and comorbidities of anxiety disorders in France: results from the "Mental Heath in General population" survey (MPHG). Eur Psychiatry 26: 339-345
39. Lejoyeux M, Lehert P (2011): Alcohol-use disorders and depression: results from individual patient data meta-analysis of the acamprosatecontrolled studies. Alcohol Alcohol 46 (1): 61-67
40. Liang W, Chikritzhs T, Lenton S (2011): Affective disorders and anxiety disorders predict the risk of harmful use and dependence Addiction doi: 10.1111/j.1360-0443.2011.03362
41. Marmorstein NR, Iacono WG, Malone SM (2009): Longitudinal associations between depression and substance dependence from adolescence through early adulthood. Drug Alcohol Depend 107: 154
42. Marmorstein NR, Iacono WG, Malone SM (2010): Longitudinal associations between depression and substance dependence from adolescence through early adulthood. Drug Alcohol Depend 107(2-3): 154
43. Marquenie LA, Schade A, van Balkom A et al. (2006): Comorbid phobic disorders do not influence outcome of alcohol dependence treatment. Results of a naturalistic follow-up study. Alcohol Alcohol 41: 168-173
44. Mason BJ, Kocsis JH, Ritvo EC, Cutler RB (1996): A double-blind, placebocontrolled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. JAMA 275: 761-767
45. McGrath PJ, Nunes EV, Stewart JZ et al. (1996): Imipramine treatment of alcoholics with primary depression: a placebo-controlled trial. Arch Gen Psychiatry 53: 232-240
46. Merikangas KR, Rajni LM, Molnar BE, Walters EE, Swendsen JD, Aguilar- Gaziola S, Bijl R, Borges G, Caraveo-Anduaga HH, Dewit DJ, Kolody B, Vega WA, Wittchen H-U, Kessler RC (1998): Comorbidity of substance use disorders with mood and anxiety disorders:results of the International Consortium in psychiatry Epidemiology (ICPE). Addict Behav 23: 893-907
47. Merikangas KR, Zhang H, Avenoli S, Acharyya S, Neuenschwander M, Angst J (2003): Longitudinal trajectories of depression and anxiety in a prospectice community study: the Zurich Cohort Study. Arch Gen Psychiatry 60: 993-1000
48. Moak DH, Anton RF, Latham PK, Voronin KE, Waid RL, Durazo-Arvizu R (2003): Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial. J Clin Psychopharmacol 23: 553-562
49. Moggi F (Ed.) (2007): Dual diagnosis (in German, 2ed).
50. Huber, Hogrefe, Bern Muhonen LH, Lahti J, Sinclair D, Lönnquist J, Alho H (2008a): Treatment of alcohol dependence in patients with comorbid major depressive disorder-predictors for the outcomes with memantine and escitalopram medication. Subst Abuse Treat Prev Policy 3:20:10
51. Muhonen LH, Lönnquist J, Juva K, Alho H (2008b):Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence. J Clin Psychiatry 69: 392-399
52. Mullaney JA, Trippet CJ (1979): Alcohol dependence and phobias: clinical description and relevance. Br J Psychiatry 135: 565-573
53. Nunes EV, Levin FR (2007): Treatment of Depression in patients with alcohol or other drug dependence. A meta-analysis. JAMA 291: 1187-1896
54. Palucha-Poniewiera A, Pilic A (2012): Involvement of mGlu5 and NMDA receptors in the antidepressant-like affect of acamprosate in the tail suspension test. Prog Neuropsychopharmacol Biol Psychiatry 9: 102-106
55. Pani PP, Troqu E, Vecchi S, Amato L (2011): Antidepressants for cocaine dependence and problematic cocaine use. Cochrane Database Syst Rev: CD002950
56. Prisciandaro JJ, Brown DG, Brady KT, Tolliver BK (2011): Comorbid anxiety disorders and baseline medication regimens predict clinical outcomes in individuals with co-occurring bipolar disorder and alcohol dependence: Results of a randomized controlled trial. Psychiatry Res 188 (3): 361-365
57. Prisciandaro JJ, DeSantis SM, Chiuzan C, Brown DG, Brady KT, Tolliver BK (2012): Impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate. Alcohol Clin Exp Res 36 (3): 490-496
58. Quitkin FM, Rifkin A, Kaplan J, Klein DF (1972): Phobic anxiety syndrome complicated by drug dependence and addiction: a treatable form of drug abuse. Arch Gen Psychiatry 27 (2): 159-162
59. Regier DA, Farmer ME, Rae DS et al. (1990): Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Ares (ECA) Study. JAMA 264: 2511-2518
60. Robinson J, Sareen J, Cox BJ, Bolton JM (2011): Role of Self-medication in the Development of Comorbid anxiety and Substance Use Disorders. A longitudinal investigation. Arch Gen Psychiatry 68: 800-807
61. Ross HE, Glaser FB, Germanson T (1988): The prevalence of psychiatrics disorders in patients with alcohol and other drugs problems. Arch Gen Psychitary 45 (11): 1023-1031
62. Schade A, Marquenie L, van Balkom A et al. (2005): The effectiveness of anxiety treatment on alcohol-dependent patients with a comorbid phobic disorder: a randomized controlled trial. Alcohol Clin Exp Res 29: 794-800
63. Schneier FR, Foosel TE, Hasin DS et al. (2010): Social anxiety disorder and alcohol use disorder co-morbidity in the National Epidemiologic Survey on Alcohol and related Conditions. Psychol Med 40: 977-988
64. Schuckit MA, Hesselbrock V (1994): Alcohol dependence and anxiety disorders: what is the relationship? Am J Psychiatry 151 (12): 1723-1734
65. Schuckit MA (2006): Comorbidity between substance use disorders and psychiatric conditions. Addiction 101 (Suppl 1): 76-88
66. Schuckit MA, Smith TL, Kalmijn J (2013): Relationships Among Independent Major Depressions, Alcohol Use, and Other Substance Use and Related Problems Over a 30 Years in 397 Families. J Stud Alcohol Drugs 74: 271-279
67. Smail P, Stockwell T, Canter S, Hodgson R (1984): Alcohol dependence and phobicanxiety states. I.A. prevalence study. Br J Psychiatry 144: 53-57
68. Smith JP, Book SW (2010): Comorbidity of generalized anxiety disorder and alcohol use disorders among individuals seeking outpatient substance abuse treatment. Addict Behav 35: 42-45
69. Smith RJ, Aston-Jones G (2008): Noradrenergic transmission in the extendedamygdala: role in increased drug-seeking and relapse during protracted drug abstinence. BrainStruct Funct 213 (1-2): 43-61
70. Soyka M, Kranzler HR, Berglund M, Gorelick D, Hesselbrock V, Johnson BA, Möller HJ (2008): World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and related Disorders, Part 1:Alcoholism. World J Biol Psychiatry 9: 6-23
71. Stewart SH, Zvolensky MJ, Eifert GH (2001): Negative reinforcement drinking motives mediate the relation between axiety sensitivity and increased drinking behavior. Pers indiv Differ 31: 157-171
72. Teeson M, Slade T, Mills K (2009): Comorbidity in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry 43: 600-614
73. Thomas SE, Randall CL, Carrigan MH (2003): Drinking to cope in socially anxious individuals: a controlled study. Alcohol Clin Exp Res 27 (12): 1937-1943
74. Tolliver BK, Desantis SM, Brown DG, Prisciandaro JJ, Brady KT (2012): A randomized, double-blind, placebo-controlled clinical trial of acamprosate in alcohol-dependent individuals with bipolar disorder: a preliminary report. Bipolar Disord 14 (1): 54-63
75. Tomlinson KL, Tate SR, Anderson KG, McDauthy DM, Brown SA (2006): An examination of self-medication and rebbound effects: psychiatrics symptomatology before and after alcohol or drug relapse. Addict Behav 31 (3): 461-474
76. Wallace C, Mullen P, Burgess P, Palmer S, Ruchena D, Browne C (1998): Serious criminal offending and mental disorder: case linkage study. Br J Psychiatry 172: 477-484
77. Watkins KE, Hunter SB, Hepner KA,Paddock SM, de la Crux E, Zhou AJ (2011): An effectiveness Trial of Group Cognitive Behavioural Therapy for Patients with Persistent Depressive Symptoms in Substance Abuse Treatment. Arch Gen Psychiatry 68: 577-584
78. Wittchen HU, Bühringer G, Rehm JT, Soyka M, Träder A, Mark K, Trautmann S (2011): Der Verlauf und Ausgang von Substitutionspatienten unter den aktuellen Bedingungen der Deutschen Substitutionsversorgung nach 6 Jahren. Sucht Med 13: 232-246
79. Witte J, Bentley K, Evins AE, Clain AJ, Baer L, Pedrelli P, Fava M, Mischoulon D (2012): A randomized, controlled pilot study of acamprosate added to escitalopram in adults with major depressive disorder and alcohol use disorder. J Clin Psychopharmacol 32 (6): 787-796